Detalhe da pesquisa
1.
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.
Gut
; 70(9): 1632-1641, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199443
2.
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.
Hepatology
; 72(3): 982-996, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879968
3.
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.
Gastroenterology
; 154(4): 1066-1079.e5, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113809
4.
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.
Clin Cancer Res
; 30(10): 2140-2159, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376926
5.
USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development.
Stem Cell Reports
; 18(2): 570-584, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669491
6.
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer.
Cell Oncol (Dordr)
; 44(5): 1197-1206, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462871
7.
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer.
Cell Death Differ
; 28(10): 2970-2982, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226680
8.
Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy.
Nat Commun
; 12(1): 366, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446657
9.
MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.
Cancer Discov
; 11(5): 1228-1247, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328217
10.
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer.
Nat Commun
; 11(1): 1923, 2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317663
11.
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
Oncogene
; 38(10): 1717-1733, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30353166
12.
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
Oncogene
; 38(28): 5746, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147600
13.
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial.
Clin Cancer Res
; 25(13): 3830-3838, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952636
14.
A MYC-GCN2-eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer.
Nat Cell Biol
; 21(11): 1413-1424, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31685988
15.
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.
Cancer Discov
; 8(10): 1270-1285, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30166348
16.
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Science
; 359(6378): 920-926, 2018 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472484
17.
The Dnmt3L ADD Domain Controls Cytosine Methylation Establishment during Spermatogenesis.
Cell Rep
; 10(6): 944-956, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683717
18.
The Dnmt3L ADD Domain Controls Cytosine Methylation Establishment during Spermatogenesis.
Cell Rep
; 11(6): 990, 2015 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843284